Gujarat Themis Biosyn Board of Directors
Get the latest insights into the leadership at Gujarat Themis Biosyn. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Dr. Dinesh S Patel | Chairman & Non-Exe.Director |
| Dr. Sachin D Patel | Promoter Non-Exe.Director |
| Mr. Vijay Agarwal | Ind. Non-Executive Director |
| Dr. Vikram D Sanghvi | Ind. Non-Executive Director |
| Mr. Siddharth Y Kusumgar | Ind. Non-Executive Director |
| Mrs. Kirandeep Kaur Madan | Ind. Non-Executive Director |
Gujarat Themis Biosyn Share price
GUJTHEM
381.05
12.35 (-3.14%)NSE
BSE
Last updated on 4 Sep, 2025 | 15:29 IST
BUYSELL
Today's High
401.95
Today's Low
380.25
52 Week Low
208.00
52 Week High
410.70
The current prices are delayed, login to your account for live prices
LoginGujarat Themis Biosyn FAQs
The board at Gujarat Themis Biosyn consists of experienced professionals, including Dr. Dinesh S Patel , Dr. Sachin D Patel , and others, overseeing the company’s strategic and corporate governance.
Directors at Gujarat Themis Biosyn are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Dr. Dinesh S Patel is the current chairman at Gujarat Themis Biosyn.
Executive directors at Gujarat Themis Biosyn are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Gujarat Themis Biosyn adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Gujarat Themis Biosyn, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.